| Control group | Counselling (HAP/CAP) group | Adjusted β (95%CI) | P | Effect size | ||||
---|---|---|---|---|---|---|---|---|---|
N | Mean (SD) or N (%) | Adjusted mean change (95%CI) from BL | N | Mean (SD) or N (%) | Adjusted mean change (95%CI) from BL | ||||
Depression Cohort | |||||||||
 PHQ-9 | |||||||||
  Baseline | 72 | 12.3 (2.15) | – | 60 | 13.0 (3.37) | – | – |  |  |
  Midline | 49 | 6.3 (5.06) | −6.33 (−7.77 to −4.89) | 46 | 3.9 (3.56) | −8.97 (−10.21 to − 7.72) | −2.64 (− 4.55 to −0.74) | 0.007 | − 0.56 (− 0.96, − 0.16) |
  Endline | 55 | 6.6 (4.94) | −5.50 (− 6.90 to − 4.11) | 46 | 3.4 (2.95) | −9.16 (− 10.44 to − 7.89) | −3.66 (− 5.55 to − 1.77) | < 0.001 | − 0.76 (− 1.15, − 0.37) |
 WHODAS | |||||||||
  Baseline | 72 | 30.0 (15.55) | – | 60 | 36.5 (15.50) | – | – |  |  |
  Midline | 49 | 21.7 (18.50) | − 6.89 (− 12.43 to − 1.35) | 46 | 14.1 (15.81) | −19.09 (− 24.27 to − 13.91) | − 12.20 (− 19.79 to − 4.62) | 0.002 | −0.65 (− 1.05, − 0.25) |
  Endline | 55 | 22.8 (18.89) | −5.78 (− 11.34 to − 0.22) | 46 | 13.1 (15.35) | −20.04 (− 26.33 to − 13.75) | −14.26 (− 22.65 to − 5.86) | 0.001 | −0.67 (− 1.06, − 0.27) |
AUD Cohort | |||||||||
 AUDIT | |||||||||
  Baseline | 57 | 16.4 (6.53) | – | 80 | 26.0 (6.46) | – | – |  |  |
  Midline | 28 | 16.0 (5.92) | 3.78 (0.57 to 6.98) | 63 | 10.1 (9.55) | −13.96 (− 17.88 to − 10.04) | − 17.74 (− 22.80 to − 12.67) | < 0.001 | − 1.56 (− 2.00, − 1.11) |
  Endline | 35 | 16.9 (9.04) | 2.75 (−1.72 to 7.22) | 66 | 14.9 (11.08) | −7.69 (− 12.30 to − 3.08) | − 10.45 (− 16.87 to − 4.02) | 0.001 | − 0.67 (− 1.08, − 0.26) |
 WHODAS | |||||||||
  Baseline | 57 | 17.5 (15.11) | – | 80 | 22.8 (18.64) | – | – |  |  |
  Midline | 28 | 13.4 (12.58) | −2.43 (− 8.09 to 3.24) | 63 | 11.7 (14.37) | −9.87 (− 15.15 to − 4.58) | −7.44 (− 15.19 to 0.31) | 0.060 | −0.43 (− 0.87, 0.02) |
  Endline | 35 | 15.5 (13.03) | 4.68 (− 2.97 to 12.34) | 66 | 12.6 (14.14) | − 8.39 (−14.03 to − 2.75) | −13.08 (− 22.58 to − 3.57) | 0.007 | −0.56 (− 0.97, − 0.15) |